| Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics P Shen, Y Jing, R Zhang, MC Cai, P Ma, H Chen, G Zhuang Oncogene 37 (22), 3039-3044, 2018 | 48 | 2018 |
| Autophagy activation attenuates angiotensin II-induced cardiac fibrosis S Liu, S Chen, M Li, B Zhang, P Shen, P Liu, D Zheng, Y Chen, J Jiang Archives of Biochemistry and Biophysics 590, 37-47, 2016 | 48 | 2016 |
| SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300 P Shen, X Feng, X Zhang, X Huang, S Liu, X Lu, J Li, J You, J Lu, Z Li, ... Journal of Pharmacological Sciences 132 (1), 31-40, 2016 | 41 | 2016 |
| STAT3 suppression is involved in the protective effect of SIRT6 against cardiomyocyte hypertrophy X Zhang, W Li, P Shen, X Feng, Z Yue, J Lu, J You, J Li, H Gao, S Fang, ... Journal of Cardiovascular Pharmacology 68 (3), 204-214, 2016 | 34 | 2016 |
| Receptor‐interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes J You, Z Yue, S Chen, Y Chen, X Lu, X Zhang, P Shen, J Li, Q Han, Z Li, ... Acta physiologica 220 (1), 58-71, 2017 | 26 | 2017 |
| PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy J Li, H Gao, J Huang, P Wang, Y Huang, W Luo, X Zhang, P Shen, J You, ... Journal of Pharmacological Sciences 132 (1), 15-23, 2016 | 15 | 2016 |
| SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer L Lin, K Shi, S Zhou, MC Cai, C Zhang, Y Sun, J Zang, L Cheng, K Ye, ... Oncogene 41 (12), 1767-1779, 2022 | 14 | 2022 |
| TIEG1 Inhibits Angiotensin II–induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4 Q Li, P Shen, S Zeng, P Liu Journal of cardiovascular pharmacology 66 (2), 196-203, 2015 | 11 | 2015 |
| Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer Y Jing, Y Zhang, H Zhu, K Zhang, MC Cai, P Ma, P Shen, Z Zhang, ... Oncogene 38 (16), 3047-3060, 2019 | 8 | 2019 |
| Epigenetic heterogeneity promotes acquired resistance to BET bromodomain inhibition in ovarian cancer Y Sun, Z Zhang, K Zhang, Y Liu, P Shen, M Cai, C Jia, W Wang, Z Gu, ... American Journal of Cancer Research 11 (6), 3021, 2021 | 4 | 2021 |
| Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer P Shen, K Ye, H Xiang, Z Zhang, Q He, X Zhang, MC Cai, J Chen, Y Sun, ... Science Advances 9 (47), eadj0123, 2023 | 1 | 2023 |
| Article | Published: 07 January 2019 Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancer P Shen oncogene, 0 | | |
Guanglei ZhuangShanghai Jiao Tong UniversityE-mailová adresa ověřena na: renji.com
